BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33982619)

  • 1. Individualized Fraction Regimen of SBRT Patients With Non-Small Cell Lung Cancer Based on Uncomplicated and Cancer-Free Control Probability.
    Feng AH; Wang H; Chen H; Gu HL; Shao Y; Duan YH; Huang Y; Fu XL; Zhou T; Xu ZY
    Technol Cancer Res Treat; 2021; 20():15330338211011967. PubMed ID: 33982619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
    Lu JY; Lin PX; Huang BT
    Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
    Ding M; Zollinger W; Ebeling R; Heard D; Posey R
    J Appl Clin Med Phys; 2018 Nov; 19(6):226-233. PubMed ID: 30216639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy.
    Sánchez-Nieto B; Romero-Expósito M; Terrón JA; Sánchez-Doblado F
    Phys Med; 2017 Oct; 42():277-284. PubMed ID: 28392313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
    Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
    Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
    Shang H; Pu Y; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
    Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
    Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
    [No Abstract]   [Full Text] [Related]  

  • 10. FFF-VMAT for SBRT of lung lesions: Improves dose coverage at tumor-lung interface compared to flattened beams.
    Pokhrel D; Halfman M; Sanford L
    J Appl Clin Med Phys; 2020 Jan; 21(1):26-35. PubMed ID: 31859456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
    Pokhrel D; Sanford L; Halfman M; Molloy J
    J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
    Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
    J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).
    Navarria P; Ascolese AM; Mancosu P; Alongi F; Clerici E; Tozzi A; Iftode C; Reggiori G; Tomatis S; Infante M; Alloisio M; Testori A; Fogliata A; Cozzi L; Morenghi E; Scorsetti M
    Radiother Oncol; 2013 Jun; 107(3):414-8. PubMed ID: 23725859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological analysis of stereotactic body radiation therapy for an evidence-based planning target volume of the lung using multiphase CT images obtained with a pneumatic abdominal compression apparatus: a case study.
    Chairmadurai A; Goel HC; Jain SK; Kumar P
    Radiol Phys Technol; 2017 Dec; 10(4):525-534. PubMed ID: 29128934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT.
    Zhou C; Bennion N; Ma R; Liang X; Wang S; Zvolanek K; Hyun M; Li X; Zhou S; Zhen W; Lin C; Wahl A; Zheng D
    Radiat Oncol; 2017 May; 12(1):80. PubMed ID: 28476138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.
    Huang BT; Lu JY; Lin PX; Chen JZ; Li DR; Chen CZ
    Sci Rep; 2015 Dec; 5():18010. PubMed ID: 26657569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy.
    Sanford L; Molloy J; Kumar S; Randall M; McGarry R; Pokhrel D
    J Appl Clin Med Phys; 2019 Jan; 20(1):118-127. PubMed ID: 30548205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.